Drug General Information
Drug ID
D0KY7S
Former ID
DCL001201
Drug Name
ISIS-FXI
Drug Type
Antisense drug
Indication Clotting disorders [ICD9: 286; ICD10:D65-D69] Phase 1 [551052]
Company
ISIS Pharm
Target and Pathway
Target(s) mRNA of Factor XI Target Info [551052]
KEGG Pathway Complement and coagulation cascades
PathWhiz Pathway Coagulation
Reactome Intrinsic Pathway of Fibrin Clot Formation
WikiPathways Human Complement System
Blood Clotting Cascade
Formation of Fibrin Clot (Clotting Cascade)
References
Ref 551052Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).
Ref 551052Clinical pipeline report, company report or official report of ISIS Pharmaceuticals (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.